Glossary entry (derived from question below)
English term or phrase:
dosing emulsion
Polish translation:
(DSP-7888) Dosing Emulsion
Added to glossary by
Frank Szmulowicz, Ph. D.
Jun 13, 2018 13:53
5 yrs ago
English term
dosing emulsion
English to Polish
Medical
Medical (general)
badania kliniczne
Wyrażenie pochodzi z formularza zgody na udział w badaniu klinicznym.
Randomized, Multicenter Study of XXX Dosing Emulsion
This study will help us learn more about a newly discovered vaccine drug, XXX Dosing Emulsion (or simply XXX).
Randomized, Multicenter Study of XXX Dosing Emulsion
This study will help us learn more about a newly discovered vaccine drug, XXX Dosing Emulsion (or simply XXX).
Proposed translations
(Polish)
3 | (DSP-7888) Dosing Emulsion | Frank Szmulowicz, Ph. D. |
Change log
Jun 22, 2018 09:44: Frank Szmulowicz, Ph. D. Created KOG entry
Proposed translations
55 mins
Selected
(DSP-7888) Dosing Emulsion
To jest nazywa własna i nie powinna być tłumaczona.
This is a multicenter, open label, Phase 1 dose-escalation study of DSP-7888 Dosing Emulsion administered to adult patients with advanced malignancies. Patients will be administered escalating doses of DSP-7888 Dosing Emulsion intradermally or subcutaneously in accordance with the following regimen: once weekly for four weeks during the Induction Phase, once every 7 to 14 days for 6 weeks during the Consolidation Phase, and once every 14 to 28 days until a discontinuation criterion is met during the Maintenance Phase. Once RP2D is determined from either the intradermal or subcutaneous group, an additional 40 patients evaluable for response may be enrolled as an expansion cohort at this dose and route of administration to confirm safety and tolerability. Separate from the dose-ascending cohort and RP2D expansion cohort described previously, and once the intradermal dose-ascending cohort is completed, up to 20 MDS patients who are refractory to treatment with hypomethylating agents (HMAs) will be enrolled into an MDS expansion cohort. Of these 20 MDS patients, one-half will receive DSP-7888 at 10.5 mg according to the modified schedule employed in Phase 1 (every week for 4 weeks, every 2 weeks until Week 24, and then every 4 weeks; [MDS Cohort 1]). The other half of the MDS patients will receive DSP-7888 at 10.5 mg in an alternative dosing schedule where DSP-7888 is administered every 2 weeks until Week 24, after which it will be administered every 4 weeks (MDS Cohort 2).
https://clinicaltrials.gov/ct2/show/NCT02498665
This is a multicenter, open label, Phase 1 dose-escalation study of DSP-7888 Dosing Emulsion administered to adult patients with advanced malignancies. Patients will be administered escalating doses of DSP-7888 Dosing Emulsion intradermally or subcutaneously in accordance with the following regimen: once weekly for four weeks during the Induction Phase, once every 7 to 14 days for 6 weeks during the Consolidation Phase, and once every 14 to 28 days until a discontinuation criterion is met during the Maintenance Phase. Once RP2D is determined from either the intradermal or subcutaneous group, an additional 40 patients evaluable for response may be enrolled as an expansion cohort at this dose and route of administration to confirm safety and tolerability. Separate from the dose-ascending cohort and RP2D expansion cohort described previously, and once the intradermal dose-ascending cohort is completed, up to 20 MDS patients who are refractory to treatment with hypomethylating agents (HMAs) will be enrolled into an MDS expansion cohort. Of these 20 MDS patients, one-half will receive DSP-7888 at 10.5 mg according to the modified schedule employed in Phase 1 (every week for 4 weeks, every 2 weeks until Week 24, and then every 4 weeks; [MDS Cohort 1]). The other half of the MDS patients will receive DSP-7888 at 10.5 mg in an alternative dosing schedule where DSP-7888 is administered every 2 weeks until Week 24, after which it will be administered every 4 weeks (MDS Cohort 2).
https://clinicaltrials.gov/ct2/show/NCT02498665
Note from asker:
Dziękuję. |
4 KudoZ points awarded for this answer.
Comment: "Dziękuję"
Something went wrong...